BioInvent Extends Antibody Collaboration with Japanese Pharmaceutical Partner

LUND, Sweden--(BUSINESS WIRE)--BioInvent International AB (OMXS:BINV) today announced that it has signed an agreement to extend its existing collaboration with an undisclosed Japanese pharmaceutical group.

MORE ON THIS TOPIC